WO2000071090A1 - Oral compositions for controlling mouth and breath odors containing a zinc salt - Google Patents

Oral compositions for controlling mouth and breath odors containing a zinc salt Download PDF

Info

Publication number
WO2000071090A1
WO2000071090A1 PCT/US2000/014100 US0014100W WO0071090A1 WO 2000071090 A1 WO2000071090 A1 WO 2000071090A1 US 0014100 W US0014100 W US 0014100W WO 0071090 A1 WO0071090 A1 WO 0071090A1
Authority
WO
WIPO (PCT)
Prior art keywords
percent
weight
zmc
oral
oral composition
Prior art date
Application number
PCT/US2000/014100
Other languages
French (fr)
Inventor
Lisa Smucker
Connie Chilcot
Original Assignee
Dentsply International Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dentsply International Inc. filed Critical Dentsply International Inc.
Priority to EP00939324A priority Critical patent/EP1180009A1/en
Priority to CA002371918A priority patent/CA2371918A1/en
Publication of WO2000071090A1 publication Critical patent/WO2000071090A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • the present invention relates to oral compositions for the control of volatile compounds associated with oral malodor.
  • Oral composition means a composition for topical applications to the oral cavity to clean and care for the teeth as well as the oral cavity surfaces.
  • Representatives of such compositions are oral hygiene products and dentifrices such as mouthwashes or rmses, toothpaste, dental gels, tooth powder, chewing gum, lozenges, and similar products.
  • oral hygiene preparations In addition to cleaning teeth to remove dental plaque, the function of oral hygiene preparations is to stop the formation of dental calculus, to prevent dental disorders such as canes, pe ⁇ odontitis and gingivitis, and also to eliminate halitosis.
  • Dental plaque is a deposit which forms on teeth and consists of inorganic and organic components de ⁇ ved from saliva, food and bacteria which are present in the oral cavity.
  • HAP hydroxyapatite
  • Oral malodor, or halitosis is caused by the putrefactive activity of microorganisms on appropriate substrate components of dental plaque, deb ⁇ s adhering to mucous membranes and salivary cellular elements to produce volatile sulfur compounds
  • sulfur volatiles primarily consist of hydrogen sulfide (H,S), methyl mercaptan (CH-SH) and traces of dimethyl sulfide (CH 3 )-S.
  • Volatile sulfur compounds, aromatic ammes, ammonia and urea have also been shown to increase m the mouth of patients suffering from pe ⁇ odontal disease
  • Methods of inhibiting volatile sulfur compounds to reduce the production of mouth odor have included the use of dentifrices containing antimicrobials, such as, chlorhexidine.
  • antimicrobials such as, chlorhexidine.
  • side effects associated with chlorhexidme such as a bitter taste and staining of the teeth, tongue, gums and oral mucosa, precludes the use of chlorhexidme in oral compositions.
  • the pnor art also shows oral compositions containing zmc salts such as zmc chlo ⁇ de, zmc iodide, zmc fluonde, zmc phenol sulfonate and the like as antiseptic agents, and correctives of oral conditions such as pyorrhea.
  • Zmc chlo ⁇ de has commonly been used in oral formulations for its ast ⁇ ngency properties.
  • Zmc phenol sulfonate has been utilized m the p ⁇ or art dentifrice compositions as an anti-plaque and anti-calculus agent as well as an odor inhibitor of fermentation and putrefaction which occurs in the oral cavity.
  • Compositions m which these soluble zmc salts have been used have had the disadvantages such as leaving an unpleasant ast ⁇ ngent taste in the mouth and/or having short-lived efficacy against plaque, and as an odor inhibitor.
  • a breath freshening toothpaste includes at least one solvent, a surfactant, a thickener and an amount of a zmc compound, preferably zinc chloride.
  • a breath freshening ⁇ nse includes water and alcohol or other solvents, and an amount of a zinc component, preferably zmc chlo ⁇ de.
  • the present invention includes zmc components contained in an solvent.
  • the zmc component is a zinc salt which includes any that are physiologically acceptable m oral compositions.
  • a preferred zmc salt is zinc chloride.
  • the compositions according to the present invention also include a solvent such as water, alcohol, glyce ⁇ n or the like. Preferred solvents include sorbitol, glyce ⁇ n, polyethylene glycol, water or any similar physiologically acceptable solvent.
  • solvents such as polyethylene glycol
  • a surface-active agent or surfactant in the compositions.
  • any physiologically acceptable surfactant, such as sodium lauryl sulfate is useful in the present invention.
  • compositions according to the present invention may also be included in the compositions according to the present invention, such as for example abrasivesn (such as Zeodent), thickeners (again including for example, Zeodent), emulsifiers, sweeteners, dyes and the like, may also be included in the present compositions.
  • abrasivesn such as Zeodent
  • thickeners such as Zeodent
  • emulsifiers such as sweeteners, dyes and the like
  • a toothpaste according to the present invention may include the following: TABLE 1
  • An oral ⁇ nse composition according the present invention has the following components.
  • Flavor (Cmnamic Aldehyde) UJJ ⁇ T TJJjtJ " Sodium Sacchann (JT Baker) U ⁇ W
  • polysorbate 80 is a surfactant, namely, a polyoxyethylene fatty acid ester.
  • Poloximer 237 emulsifier a polyethylene polypropylene glycol are useful. It should be evident therefore, that the oral compositions according to the present invention and as descnbed above, carry out the objects of the invention as set forth. The present invention has been exemplified without attempting to show all of the va ⁇ ations which fall withm the scope of the invention. One skilled in the art will readily understand how to vary the composition components, amounts, and the like without departing from the scope of the invention.

Abstract

Oral compositions according to the present invention include at least one solvent, a surfactant, and a zinc compound, such as zinc chloride.

Description

ORAL COMPOSITIONS FOR CONTROLLING MOUTH AND BREATH ODORS CONTAINING A ZINC S T
BACKGROUND OF THE INVENTION The present invention relates to oral compositions for the control of volatile compounds associated with oral malodor.
"Oral composition" means a composition for topical applications to the oral cavity to clean and care for the teeth as well as the oral cavity surfaces. Representatives of such compositions are oral hygiene products and dentifrices such as mouthwashes or rmses, toothpaste, dental gels, tooth powder, chewing gum, lozenges, and similar products. In addition to cleaning teeth to remove dental plaque, the function of oral hygiene preparations is to stop the formation of dental calculus, to prevent dental disorders such as canes, peπodontitis and gingivitis, and also to eliminate halitosis. Dental plaque is a deposit which forms on teeth and consists of inorganic and organic components deπved from saliva, food and bacteria which are present in the oral cavity. When plaque undergoes calcification it forms dental calculus, or tartar as it is sometimes called. Dental calculus is largely calcium and orthophosphate arranged m a crystal lattice called hydroxyapatite (HAP). Oral malodor, or halitosis, is caused by the putrefactive activity of microorganisms on appropriate substrate components of dental plaque, debπs adhering to mucous membranes and salivary cellular elements to produce volatile sulfur compounds These sulfur volatiles primarily consist of hydrogen sulfide (H,S), methyl mercaptan (CH-SH) and traces of dimethyl sulfide (CH3)-S. Volatile sulfur compounds, aromatic ammes, ammonia and urea have also been shown to increase m the mouth of patients suffering from peπodontal disease Methods of inhibiting volatile sulfur compounds to reduce the production of mouth odor have included the use of dentifrices containing antimicrobials, such as, chlorhexidine. However, the side effects associated with chlorhexidme, such as a bitter taste and staining of the teeth, tongue, gums and oral mucosa, precludes the use of chlorhexidme in oral compositions.
The pnor art also shows oral compositions containing zmc salts such as zmc chloπde, zmc iodide, zmc fluonde, zmc phenol sulfonate and the like as antiseptic agents, and correctives of oral conditions such as pyorrhea. Zmc chloπde has commonly been used in oral formulations for its astπngency properties. Zmc phenol sulfonate has been utilized m the pπor art dentifrice compositions as an anti-plaque and anti-calculus agent as well as an odor inhibitor of fermentation and putrefaction which occurs in the oral cavity. Compositions m which these soluble zmc salts have been used have had the disadvantages such as leaving an unpleasant astπngent taste in the mouth and/or having short-lived efficacy against plaque, and as an odor inhibitor.
A need exists therefore for an oral composition to control mouth and breath odors and which does no have the unpleasant taste associated with previous oral compositions.
DISCLOSURE OF THE INVENTION
It is therefore an object of the present invention to provide an oral composition.
It is another object of the present invention to provide an oral composition which controls mouth and breath odors. It is a further object of the invention to provide oral compositions in the nature of dentπfπces, including mouth πnses and toothpastes. These and other objects of the present invention which shall become apparent from the specification to follow are accomplished by the invention as hereinafter descπbed.
In general, according to the present invention, a breath freshening toothpaste includes at least one solvent, a surfactant, a thickener and an amount of a zmc compound, preferably zinc chloride.
According to another embodiment of the invention, a breath freshening πnse includes water and alcohol or other solvents, and an amount of a zinc component, preferably zmc chloπde.
PREFERED EMBODIMENTS FOR CARRYING OUT THE INVENTION
The present invention includes zmc components contained in an solvent.
Preferably, the zmc component is a zinc salt which includes any that are physiologically acceptable m oral compositions. A preferred zmc salt is zinc chloride. The compositions according to the present invention also include a solvent such as water, alcohol, glyceπn or the like. Preferred solvents include sorbitol, glyceπn, polyethylene glycol, water or any similar physiologically acceptable solvent.
It is understood that certain of the solvents, such as polyethylene glycol, can also act as a humectant. It is also preferred to include a surface-active agent or surfactant in the compositions. Again, any physiologically acceptable surfactant, such as sodium lauryl sulfate is useful in the present invention.
Other components may also be included in the compositions according to the present invention, such as for example abrasivesn (such as Zeodent), thickeners (again including for example, Zeodent), emulsifiers, sweeteners, dyes and the like, may also be included in the present compositions.
A toothpaste according to the present invention may include the following: TABLE 1
BREATH FRESHENING TOOTHPASTE
Figure imgf000005_0001
An oral πnse composition according the present invention has the following components.
TABLE 2
ORAL RINSE INGREDIENTS
Ethanol (PharmCo) TΠΓ TΠΓ
Polysorbate 80 (1CI) 0.40-044 H4 " Pluro c F 7 (BASF) 0.40-0.44
Zmc Chloπde (JT Baker) TTT5" ux5~ Sodium citrate (J 1 Baker) TUT U Γ
Flavor (Mint) TΠ Γ ΓΠΓ
Flavor (Cmnamic Aldehyde) UJJΪT TJJjtJ" Sodium Sacchann (JT Baker) UλW
Citπc Acid (JT Baker) 0.01 0.01
FD&C Blue 31 (Werner Jenkinson) 0.0002 0.0002
100
In the above formulas, polysorbate 80 is a surfactant, namely, a polyoxyethylene fatty acid ester. Poloximer 237 emulsifier (a polyethylene polypropylene glycol) are useful. It should be evident therefore, that the oral compositions according to the present invention and as descnbed above, carry out the objects of the invention as set forth. The present invention has been exemplified without attempting to show all of the vaπations which fall withm the scope of the invention. One skilled in the art will readily understand how to vary the composition components, amounts, and the like without departing from the scope of the invention.

Claims

What is claimed is:
1. An oral composition for controlling odors comprising: a zmc salt, a physiologically acceptable solvent and a physiologically acceptable surface active agent.
2. An oral composition as in claim 1, wherein said zinc salt is zmc chloπde.
3. An oral composition as in claim 1 , wherein said solvent is selected from the group consisting of water, alcohol, glyceπn and mixtures thereof.
4. An oral composition as in claim 1 , wherein said solvent is selected from the group consisting of sorbitol, polyethylene glycol and mixtures thereof.
5. An oral composition as in claim 1, wherein said surface active agent is sodium lauryl sulfate.
6. An oral composition as m claim 1, further compπsmg an abrasive component.
7. A breath-freshenmg oral composition m the form of a toothpaste compπsing: from about 35 to about 40 percent by weight of sorbitol; from about 23 to about 27 percent by weight of a thickener; about 20 percent by weight of glycenn; about 8 to about 12 percent by weight of water; about 3 percent by weight of polyethylene glycol; about 1.2 percent by weight of sodium lauryl sulfate; about 1 percent by weight of zmc chloπde; each component based upon 100 percent by weight of the total composition.
8. A breath-freshenmg oral nnse compπsing:
About 85 to about 90 percent by weight of water; about 11 percent by weight of ethanol; about 0.4 to about 0.44 percent by weight of a polyoxyethylene fatty acid ester surfactant: 0 4 to about 0.44 percent by weight of Pluruonic surfactant; and about 0.15 percent by weight of zmc chloπde; each component based upon 100 percent by weight of the total composition.
PCT/US2000/014100 1999-05-26 2000-05-23 Oral compositions for controlling mouth and breath odors containing a zinc salt WO2000071090A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00939324A EP1180009A1 (en) 1999-05-26 2000-05-23 Oral compositions for controlling mouth and breath odors containing a zinc salt
CA002371918A CA2371918A1 (en) 1999-05-26 2000-05-23 Oral compositions for controlling mouth and breath odors containing a zinc salt

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13607099P 1999-05-26 1999-05-26
US60/136,070 1999-05-26

Publications (1)

Publication Number Publication Date
WO2000071090A1 true WO2000071090A1 (en) 2000-11-30

Family

ID=22471144

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/014100 WO2000071090A1 (en) 1999-05-26 2000-05-23 Oral compositions for controlling mouth and breath odors containing a zinc salt

Country Status (3)

Country Link
EP (1) EP1180009A1 (en)
CA (1) CA2371918A1 (en)
WO (1) WO2000071090A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3085416A1 (en) * 2015-04-23 2016-10-26 Laboratoires Chemineau Liquid or semi-liquid composition made of plants from the ericaceae family for oral application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082841A (en) * 1975-10-10 1978-04-04 Lever Brothers Company Dentifrice
EP0396232A2 (en) * 1989-03-13 1990-11-07 Vipont Pharmaceutical, Inc. Oral rinse compositions
EP0436284A1 (en) * 1990-01-03 1991-07-10 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Stable oral composition of zinc
WO1997040812A1 (en) * 1996-04-26 1997-11-06 Warner-Lambert Company Enhanced zinc containing oral composition
US5948390A (en) * 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082841A (en) * 1975-10-10 1978-04-04 Lever Brothers Company Dentifrice
EP0396232A2 (en) * 1989-03-13 1990-11-07 Vipont Pharmaceutical, Inc. Oral rinse compositions
EP0436284A1 (en) * 1990-01-03 1991-07-10 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Stable oral composition of zinc
WO1997040812A1 (en) * 1996-04-26 1997-11-06 Warner-Lambert Company Enhanced zinc containing oral composition
US5948390A (en) * 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3085416A1 (en) * 2015-04-23 2016-10-26 Laboratoires Chemineau Liquid or semi-liquid composition made of plants from the ericaceae family for oral application

Also Published As

Publication number Publication date
EP1180009A1 (en) 2002-02-20
CA2371918A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
US11406573B2 (en) Oral care compositions
US11337903B2 (en) Oral care compositions
WO1994014406A1 (en) Oral compositions containing antiplaque, anticalculus agents
EP0162574A2 (en) Oral hygiene compositions
US20080184510A1 (en) Products for Tongue Cleaning and for Preventing and Treaing Halitosis and Equipment for Tongue Cleaning
JP2001518064A (en) Anticalculus toothpaste containing highly soluble pyrophosphate
JPH02286613A (en) New composition
WO2005072691A1 (en) Composition for inhibiting halitosis
CA2754213C (en) Desensitizing dentifrice exhibiting dental tissue antibacterial agent uptake
JP3753868B2 (en) Oral composition
WO2000071090A1 (en) Oral compositions for controlling mouth and breath odors containing a zinc salt
JP3578560B2 (en) Oral composition containing sulfosuccinic surfactant
CA2481004A1 (en) Novel anti-bacterial compositions
JPH08268855A (en) Composition for oral cavity
JP3305108B2 (en) Toothpaste composition
WO2002041862A1 (en) An oral hygiene preparation for inhibiting halitosis
JP2003231621A (en) Composition for oral cavity for preventing foul breath
EP1041959A1 (en) Compositions for inhibiting gingivitis
WO2001074324A1 (en) New formulations for the removal of dental plaque, tartar and dental stains
GB2412586A (en) Polyaspartate to treat dental tartar
AU2003213864C1 (en) Novel anti-bacterial compositions
JP2005289848A (en) Dentifrice

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2371918

Country of ref document: CA

Ref country code: CA

Ref document number: 2371918

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000939324

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000939324

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000939324

Country of ref document: EP